Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0020437 (hypercalcemia)
 10,293 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Freshwater catfish, Heteropneustes fossilis, were injected daily intraperitoneally either with vehicle (0.05 ml of 95% ethanol/100 g body wt) or vitamin D3 (50 I.U./100 g body wt) and maintained in artificial fresh water, calcium-rich fresh water, or calcium-deficient fresh water for 10 days. The specimens were sacrificed on Days 1, 3, 5, and 10 after initiation of the experiment. The blood samples were collected on these intervals and serum calcium and inorganic phosphate levels were analyzed. Vitamin D3 induced hypercalcemia and hyperphosphatemia in the freshwater catfish, H. fossilis. These effects of vitamin D3 are not dependent upon the calcium concentration of the different ambient media used in this study.
Gen Comp Endocrinol 1992 Jul
PMID:Effect of vitamin D3 administration on the serum calcium and inorganic phosphate levels of the freshwater catfish, Heteropneustes fossilis, maintained in artificial fresh water, calcium-rich fresh water, and calcium-deficient fresh water. 132 May 83

An enzyme-linked immunosorbent assay (ELISA) was developed to quantify stanniocalcin (STC) levels in tissue extracts and plasma samples. The detection limit of the competitive ELISA described is 0.2 ng STC per well, allowing detection of 3.7 pmol.liter-1 (assuming a molecular mass of 54,000 Da for native STC). The particular antiserum detects STC in plasma obtained from a variety of freshwater and seawater species. In freshwater post-smolt Salmo salar plasma, STC levels were significantly lower (around 0.74 nmol.liter-1) than those of seawater smolts (around 2.78 nmol.liter-1). Seven days after removal of Stannius corpuscles from freshwater eels a significant hypercalcemia was observed as well as a drop in plasma STC levels (from 2.33 to 0.67 nmol.liter-1).
Gen Comp Endocrinol 1992 Apr
PMID:An enzyme-linked immunosorbent assay for stanniocalcin, a major hypocalcemic hormone in teleost. 150 18

In pregnant women with symptomatic hyperparathyroidism, parathyroidectomy should be undertaken during the second trimester. We feel that the woman who is initially diagnosed well into the third trimester should be treated medically unless the hypercalcemia worsens or other complications occur. Since the treatment of asymptomatic hyperparathyroidism itself is controversial, it is even more difficult to define the treatment plan for an asymptomatic pregnant patient who has primary hyperparathyroidism. However, a recent consensus panel recommended that young patients with asymptomatic hyperparathyroidism be treated surgically. Accordingly, we believe that the asymptomatic pregnant patient should also be treated surgically, preferably in the second trimester. Whether a patient is treated medically or surgically in these situations, the pregnancy should be considered high-risk. The neonate should be monitored carefully for signs of hypocalcemia or impending tetany. If the mother is treated medically to term (or if spontaneous or elective abortion occurs), the mother should be monitored for hyperparathyroid crisis postpartum. Sudden worsening of hypercalcemia can result from the loss of the placenta (active placental calcium transport may be somewhat protective) and dehydration. Finally, every effort should be made to make the definitive diagnosis early in pregnancy in order to initiate optimal management. The diagnosis should be suspected during pregnancy if the following conditions exist: appropriate clinical signs or symptoms (especially nephrolithiasis or pancreatitis), hyperemesis beyond the first trimester, history of recurrent spontaneous abortions/stillbirths or neonatal deaths, neonatal hypocalcemia or tetany, or a total serum calcium concentration greater than 10.1 mg/dL (2.52 mmol/L) or 8.8 mg/dL (2.2 mmol/L) during the second or third trimester, respectively.
J Gen Intern Med
PMID:Hyperparathyroidism and pregnancy: case report and review. 150 54

Embryonic chickens were exposed to 0, 30, or 300 pg of calcitriol per day via slow-release pellets implanted adjacent to the chorioallantoic membrane. Pellets were placed in eggs on Days 10 and 15, and eggs were sampled on Days 12 and 17, respectively. The hormone induced high mortality among embryos receiving pellets on Day 10, but not among those whose treatment was begun on Day 15. Embryos receiving hormone were hypercalcemic and hypophosphatemic on both Day 12 and Day 17, but the concentration of magnesium in plasma was not affected. Size of embryos sampled on Day 12 was not affected by hormone treatment, but embryos sampled on Day 17 showed a dose-related reduction in size. Yolk-free carcasses of the embryos sampled on Day 17 also showed dose-dependent reductions in phosphorus and magnesium, but calcium content of carcasses on Day 17 was unaffected by treatment. These results indicate that both younger and older embryos respond to very small quantities of calcitriol administered via slow-release pellets. The absence of sustained hypercalcemia in earlier studies that used this protocol to dispense hormone was not caused by exposing older embryos to subthreshold quantities of calcitriol. The fact that reduced body size in late embryos receiving calcitriol was not accompanied by a reduction also in calcium content may mean that embryos deposit calcium in the carcass in an effort to deal with the extreme hypercalcemia induced by calcitriol.
Gen Comp Endocrinol 1992 Jan
PMID:Variation during development in the response of chicken embryos to calcitriol administered via slow-release pellets. 156 15

Prolactin (PRL) was purified from chum salmon, Oncorhynchus keta, pituitary glands and was used to develop a homologous radioimmunoassay for the measurement of PRL from salmon. The plasma PRL response to freshwater (FW) transfer differed in seawater (SW)-adapted postsmolt (250 g) and smolts (15 g) of coho salmon. Postsmolts had a pronounced and prolonged elevation of plasma titers of PRL with hypercalcemia and stable plasma sodium levels. The FW-transferred postsmolts had significantly lower pituitary gland PRL only at 0.5 and 2 hr post-transfer as compared to SW-SW. Smaller smolts showed stable plasma PRL levels after FW transfer, hypocalcemia 48 post-transfer, depressed plasma sodium concentrations, and lowered plasma osmotic pressure. This different response may be due to an increased osmoionic regulatory challenge encountered by the smaller smolts or possibly due to some other developmental change between the two different age classes.
Gen Comp Endocrinol 1990 May
PMID:Differential response of plasma prolactin to freshwater transfer of smolts and postsmolts of seawater-adapted coho salmon (Oncorhynchus kisutch). 235 71

In order to examine the dynamics of ion regulation, osmoregulation, and plasma calcitonin during the parr-smolt transformation (smoltification), blood and gill tissue were collected from yearling coho salmon, Oncorhynchus kisutch, from February to October. Fish were kept in fresh water (FW) throughout this period. In addition, fish were exposed to seawater (SW) at the peak of smoltification in mid-April, and samples from these fish were collected until July. Plasma osmolality, gill Na+,K+-ATPase activity, plasma levels of calcitonin, and free and total calcium and magnesium were measured. SW adaptability of FW fish was assessed throughout the study by measurements of plasma osmolality following a 24-hr exposure to seawater. The greatest hypoosmoregulatory ability occurred in April-May, although SW-adapted fish had higher plasma osmolality than FW-adapted fish at all times. Gill Na+,K+-ATPase activity in FW-adapted fish increased from April to June and increased rapidly following exposure of fish to SW, and remained elevated in SW-adapted fish. Free plasma calcium and magnesium levels increased following SW exposure, but returned to prior levels within 1 week. Netting and confinement stress during sampling caused an increase in plasma osmolality and free calcium and magnesium levels in both FW- and SW-adapted fish. Changes in hypoosmoregulatory ability during smoltification and SW adaptation were correlated with changes in gill Na+,K+-ATPase activity. A sharp transitory peak in plasma calcitonin levels occurred early in smoltification (March) and in SW-adapted fish in June. Plasma calcitonin levels gradually increased in FW-adapted fish during the period of desmoltification. However, no change in plasma calcitonin levels occurred during SW-induced hypercalcemia, suggesting that the hormone does not play a major role in short-term plasma calcium regulation in coho salmon.
Gen Comp Endocrinol 1989 Jun
PMID:Smoltification and seawater adaptation in coho salmon (Oncorhynchus kisutch): plasma calcium regulation, osmoregulation, and calcitonin. 254 13

The effect of salmon calcitonin (0.25 MRC mU/g body wt) was investigated on the serum calcium and inorganic phosphate levels of the frog. Rana tigrina. The hormone evokes hypocalcemia (on Day 1 and Day 3) which is followed by a significant hypercalcemia on Day 10. Thereafter, the level of calcium decreases again on Day 15. Calcitonin induces hypophosphatemia (on Day 3 and Day 5). Thereafter, hyperphosphatemia is recorded on Day 10. Normal serum phosphate value is achieved by Day 15. The results obtained in R. tigrina have been discussed in relation to the increased calcium deposits in the paravertebral lime sacs and to the possible enhanced secretion of the parathyroid glands.
Gen Comp Endocrinol 1989 Apr
PMID:Influence of calcitonin administration of serum calcium and inorganic phosphate level of the frog, Rana tigrina. 273 50

This is a comparative study of the glycoprotein hormone, teleocalcin, from the corpuscles of Stannius of sockeye (Oncorhynchus nerka) and coho (O. kisutch) salmon. Coho teleocalcin was purified by the same procedures used previously to obtain sockeye teleocalcin and was obtained in a comparable yield. Both salmon teleocalcins had the same molecular weight as estimated by sodium dodecyl sulfate-electrophoresis and both appeared to have the structure of disulfide-linked oligomers. The two hormones were similar on the basis of amino acid and carbohydrate composition and shared 95% homology in the first 40 residues on the N-terminal. The salmon teleocalcins also shared 80% homology with the predicted 1-40 N-terminal sequence from Australian eels (Anguilla australis). Both teleocalcins had potent inhibitory effects on gill calcium uptake in intact rainbow trout (Salmo gairdneri). However, these effects were observed only at the peak in the calcium uptake cycle that is displayed by this species. In North American eels (A. rostrata), the acute administration of both teleocalcins caused significant inhibition of gill calcium uptake without any concomitant changes in plasma calcium levels or other plasma electrolytes. In 4- and 7-day stanniectomy (STX) eels, the acute administration of coho teleocalcin significantly reduced or completely abolished the accelerated gill calcium transport that occurs postoperatively, with no concomitant changes in plasma electrolytes or post-STX hypercalcemia. These experiments provide further evidence that teleocalcin is a regulator of gill calcium transport and has no acute hypocalcemic effects in fish.
Gen Comp Endocrinol 1988 Nov
PMID:Comparative biochemistry and physiology of teleocalcin from sockeye and coho salmon. 319 44

After 7 days in air on wet filter paper mudskippers had normal body weight and normal levels of plasma sodium, potassium, and phosphate. They were, however, significantly hypercalcemic. The hypercalcemia could be reduced by the daily intraperitoneal injection of synthetic eel calcitonin (1.67 microgram kg-1 day-1) and this effect was dose dependent with a maximal response at a dose of 3.33 micrograms kg-1 day-1. Calcitonin had no effect on plasma calcium levels of fish held in water but did induce significant hyperphosphatemia whether the fish were held in water or in air on wet filter paper with this effect being greater under the latter conditions. The hypocalcemic action of calcitonin was restricted to conditions under which the fish displayed patent hypercalcemia. Under no conditions did calcitonin produce significant hypocalcemia so it appears that the action of synthetic eel calcitonin in the mudskipper, Periophthalmodon schlosseri, is dependent upon the presence of excess plasma calcium and is thus more accurately described as being anti-hypercalcemic rather than hypocalcemic.
Gen Comp Endocrinol 1988 May
PMID:Effects of calcitonin on plasma calcium and phosphate in the mudskipper, Periophthalmodon schlosseri (Teleostei), in water and during exposure to air. 338 5

Plasma concentrations of vitamin D3 (cholecalciferol) metabolites have been studied in rainbow trout (Salmo gairdneri) adapted to varying environmental calcium concentrations in both fresh water and artificial seawater, and in natural seawater. In vivo, intraarterial injection of tritiated 25-hydroxycholecalciferol was followed by its transformation to a number of metabolites including compounds that cochromatographed on high performance liquid chromatography (HPLC) with 1,25-dihydroxycholecalciferol and 25,26-dihydroxycholecalciferol. Hypercalcaemia and increased environmental calcium were associated with a greater transformation to the compound cochromatographing with 25,26-dihydroxycholecalciferol, while hypocalcaemia and reduced environmental calcium concentrations induced more conversion to the 1,25-dihydroxycholecalciferol-like compound. In vitro, both metabolites were produced by liver but not by kidney preparations, and the difference in conversion ratios observed in vivo associated with changes in plasma calcium were also seen in vitro. It is concluded that the metabolism of 25-hydroxycholecalciferol in the trout can be influenced by calcium status, but at present the physiological importance of this metabolism and the mechanisms and site(s) of action of the metabolites are unknown.
Gen Comp Endocrinol 1986 Oct
PMID:Metabolism of 25-hydroxycholecalciferol in a teleost fish, the rainbow trout (Salmo gairdneri). 355 76


1 2 3 4 Next >>